419 related articles for article (PubMed ID: 14294764)
1. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
BACK N; HIRAMOTO R; AMBRUS JL
Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
[No Abstract] [Full Text] [Related]
2. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
HUME M
J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
[No Abstract] [Full Text] [Related]
3. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
LEWIS JH; KERBER CW; WILSON JH
Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
[No Abstract] [Full Text] [Related]
4. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
DOUGLAS AS; MCNICOL GP
Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
[No Abstract] [Full Text] [Related]
5. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
JUERGENS J
Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
[No Abstract] [Full Text] [Related]
6. THROMBOLYTIC THERAPY.
DOUGLAS AS; MCNICOL GP
Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
[No Abstract] [Full Text] [Related]
7. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
JAMES DC; BROWSE NL
Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
[No Abstract] [Full Text] [Related]
8. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.
TSAPOGAS MJ
Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330
[No Abstract] [Full Text] [Related]
9. THROMBOLYTIC THERAPY.
FLUTE PT
J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
[No Abstract] [Full Text] [Related]
10. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
ADAMIS DM; MANIATIS GM
Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
[No Abstract] [Full Text] [Related]
11. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
SHIRAI T
Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
[No Abstract] [Full Text] [Related]
12. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
TYLER HM; LACK CH
Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
[No Abstract] [Full Text] [Related]
13. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
COON WW
Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
[No Abstract] [Full Text] [Related]
14. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
HELLE I; AAS K; GODAL HC
Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
[No Abstract] [Full Text] [Related]
15. CURRENT STATUS OF THROMBOLYTIC THERAPY.
SHERRY S
Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
[No Abstract] [Full Text] [Related]
16. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
MATTIOLI G; RABITTI G; NAVA C
Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
[No Abstract] [Full Text] [Related]
17. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
BLIX S
Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
[No Abstract] [Full Text] [Related]
18. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
JOHNSON AJ; NEWMAN J
Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
[No Abstract] [Full Text] [Related]
19. EFFECTS OF FIBRINOLYTIC AGENTS ON EXPERIMENTAL AND CLINICAL THROMBOSIS.
TSAPOGAS MJ
J Clin Pathol; 1964 May; 17(3):360-1. PubMed ID: 14159483
[No Abstract] [Full Text] [Related]
20. [INFLUENCE OF EXPERIMENTAL VASCULAR THROMBOSIS ON FIBRINOLYSIS].
STOICA E; COSTA-FORU D
Stud Cercet Neurol; 1965 Feb; 10():17-21. PubMed ID: 14340561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
